H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Census population 123,851. Michigan Medicare wound biologics: WPS Government Health Administrators (J8). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ann Arbor clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ann Arbor storefront.
Platelet Rich Plasma (PRP) Therapy in Ann Arbor, MI for clinics & physicians. PRP therapy systems with 1-m… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 6.4% of adults in Ann Arbor have diagnosed diabetes — 5.6 points below the U.S. 12% figure. Census city-proper population is 123,851. If you are adding platelet rich plasma therapy, start with that epidemiology and with WPS Government Health Administrators (J8) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)J8 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Ann Arbor is 6.4% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J8 articles mapped. 6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 6.4% of adults — 5.6 points below the U.S. 12% figure. Obesity is 25.8%; arthritis is 16.7%. That is place-level BRFSS modeling, not a clinic census and not a Ann Arbor trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Michigan.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill J8 FFS, Advantage, workers’ comp, or cash-pay.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
If you operate in Michigan and another MAC state, say it on the first call. J8 will not port 1:1. We would rather split utilization than watch a sister clinic copy Ann Arbor tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Ann Arbor, MI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ann Arbor is J8 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ann Arbor — 5.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Michigan Part B wound biologics follow this contractor (siblings: IN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ann Arbor. Useful for joint-program math; still needs a diagnosis and privileging.
No Ann Arbor storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.